Inside eLife: We collect ORCIDs from authors of accepted papers at proofing

Inside eLife: We collect ORCIDs from authors of accepted papers at proofing

Tuesday, March 7, 2017 - 15:38

The open-access eLife journal is collecting ORCID iDs during its production process in addition to the peer-review stage. Contributing authors will now be required to provide their validated iDs at the proofing stage and gain access to their article proofs. Melissa Harrison, Head of Production Operations at eLife, shares more.

 

Authenticating researchers’ ORCIDs can be a daunting task for scholarly publishers, particularly for works with multiple authors. Requesting iDs from the corresponding author is the logical first step, whether by offering ORCID as a sign-in or registration option, or by allowing authors to link their profile in the manuscript submission platform with their iD. Many publishers now collect authenticated iDs from co-authors during the submission process and embed them in the manuscript’s metadata.

eLife is delighted to announce that we have taken our ORCID integration one step further, by giving contributing authors an opportunity to associate their authenticated ORCID iD with their work during the production process. When corresponding authors share the proof link with their co-authors, they are required to sign in via ExeterPremedia’s Kriya platform using their ORCIDs, which will then be collected and displayed with the article and delivered downstream to platforms such as PubMed and Crossref.

eLife, together with PLOS and The Royal Society, was the driving force behind an open letter published in January last year, committing to requiring ORCIDs in publication workflows. We were one of the original signatories and among the first to implement our ORCID mandate for submitting authors. We have been keen to collect authenticated iDs during the production process because we often receive requests to add ORCIDs at this stage. We see this as the best solution for both our authors and our workflow, as it enables even more authors to uniquely connect themselves with their eLife papers. Authors also benefit from the ORCID auto-update process by having their authenticated ORCIDs submitted to Crossref.

As well as showing our support for ORCID by signing the open letter, eLife is one of ORCID’s first member organisations to qualify for its Collect badge – part of its Collect & Connect initiative to encourage a community-based approach to developing integrations that benefit researchers, their organisations, and the wider scholarly community.

Authors who authenticate their ORCIDs during the production process will benefit later down the line, as eLife will retain their iDs within their profiles. Our reviewers are already benefitting from the initiative through the peer-review functionality, which enables us to add their reviewing activities for eLife to their ORCID records.

Contributing authors will be able to authenticate their ORCID iDs during eLife’s production process from today (Tuesday, March 7). Other publishers using the ExeterPremedia production platform will also be able to start collecting iDs during this stage.

To learn more about ORCID, visit: http://orcid.org

For more information, please contact:

Emily Packer, Press Officer, eLife

e.packer@elifesciences.org

01223 855373

About eLife

eLife is a unique collaboration between the funders and practitioners of research to improve the way important research is selected, presented, and shared. eLife publishes outstanding works across the life sciences and biomedicine -- from basic biological research to applied, translational, and clinical studies. All papers are selected by active scientists in the research community. Decisions and responses are agreed by the reviewers and consolidated by the Reviewing Editor into a single, clear set of instructions for authors, removing the need for laborious cycles of revision and allowing authors to publish their findings quickly. eLife is supported by the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust. Learn more at elifesciences.org.